The Division of Cardiovascular Medicine is directed by Dr. Dan Roden (Interim Division Chief) and Dr. Daniel Munoz (Interim Co-Director for Clinical Affairs). The Division is comprised of more than 140 faculty members dedicated to understanding, preventing, and treating cardiovascular disease.
Our physicians perform approximately 130,000 clinic visits annually. We offer the most advanced technologies to treat coronary artery disease, arrhythmias, and structural heart disease in new, state-of-the-art cardiac catheterization and electrophysiology laboratories. In 2018, our heart transplant program was the second busiest in the world, with 100 adult heart transplants performed that year. Our multi-disciplinary programs in prevention, lipid management, inherited heart disease, adult congenital heart disease, vascular medicine, and cardio-oncology are unique in the region and among the busiest nationally.
A fundamental component of our mission is research aimed at understanding the causes of cardiovascular disease and the translation of this knowledge to improve patient care. Our faculty are recognized nationally and internationally for their work in basic, clinical, and translational investigation. Our research programs occupy more than 30,000 square feet of laboratory space on the Vanderbilt campus. Since 2013, NIH funding to the Division has increased by 2.6-fold, and overall extramural funding has increased by 70%.
We train nearly 40 fellows per year in our general fellowship and advanced sub-specialty training programs. Research training is supported by a cardiovascular T32 program that has been continuously funded by the NIH for more than 3 decades.
We welcome you to browse the sections of this website to learn more about our Division and the opportunities we offer.
Your generous gift supports our accredited program for training outstanding physicians and physician-scientists in all major areas of Cardiovascular Medicine and Advanced Subspecialty Fellowship training programs.